When Should Clinicians Act on Non-Statistically Significant Results from Clinical Trials?

Paul J. Young; Christopher P. Nickson; Anders Perner

doi:10.1001/jama.2020.3508

When Should Clinicians Act on Non-Statistically Significant Results from Clinical Trials?

Paul J. Young^*
, Christopher P. Nickson
, Anders Perner

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	JAMA - Journal of the American Medical Association
Vol/bind	323
Udgave nummer	22
Sider (fra-til)	2256-2257
Antal sider	2
ISSN	0098-7484
DOI	https://doi.org/10.1001/jama.2020.3508
Status	Udgivet - 2020

Finansiering

Conflict of Interest Disclosures: Dr Young reported receiving a research fellowship from Health Research Council of New Zealand during the conduct of the study. Dr Perner reported receiving grants from Novo Nordisk Foundation outside the submitted work. No other disclosures were reported.

Adgang til dokumentet

10.1001/jama.2020.3508

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{5d54b568a9e045039189393ab42b332b,

title = "When Should Clinicians Act on Non-Statistically Significant Results from Clinical Trials?",

author = "Young, \{Paul J.\} and Nickson, \{Christopher P.\} and Anders Perner",

year = "2020",

doi = "10.1001/jama.2020.3508",

language = "English",

volume = "323",

pages = "2256--2257",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",